Second-line Chemotherapy in Castration Resistant Prostate Cancer

NCT01558219 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Tampere University Hospital

Collaborators